FdaApplication
ANDA 201971
Identifiers
- fda_app_no: ANDA201971
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA USA INC |
| application_type | ANDA |
| approval_date | 2017-05-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RASAGILINE MESYLATE | RASAGILINE MESYLATE | EQ 0.5MG BASE | TABLET;ORAL |
| RASAGILINE MESYLATE | RASAGILINE MESYLATE | EQ 1MG BASE | TABLET;ORAL |
2 products